The period from July 7, 2023, to June 30, 2024, witnessed The University of Texas's MD Anderson in Houston leading the pack in managing Clostridioides difficile (C. diff) infections among cancer treatment centers. Notably, this institution achieved the lowest rate of C. diff infections compared to other cancer hospitals, which are exempted from mandatory reporting…